Results 161 to 170 of about 58,085 (295)

A combination of dipeptidyl peptidase-4 inhibitor and metformin in the treatment of patients with type 2 diabetes mellitus: effective control of glycemia, weight, and quantitative body composition

Терапевтический архив, 2013
AIM: To study the impact of intensified therapy with the dipeptidyl peptidase-4 (DPP-4) inhibitor vilagliptin or sulfonylurea (SU) on the control of glycemia, weight, and quantitative body composition in patients with type 2 diabetes mellitus (DM-2) who ...
M V Shestakova, O Iu Sukhareva, T O Chernova, I A Shmushkovich, A A Aleksandrov, A V Il'in, I I Dedov   +6 more
doaj  

ERRATUM: Effects of dipeptidyl peptidase-4 inhibitor in insulin-resistant rats with myocardial infarction. [PDF]

J Endocrinol
Apaijai N, Inthachai T, Lekawanvijit S, Chattipakorn SC, Chattipakorn N.   +4 more
europepmc   +1 more source

Bullous pemphigoid associated with use of dipeptidyl peptidase-4 inhibitor. [PDF]

CMAJ, 2022
Kano Y, Kato M.
europepmc   +1 more source

Pharmacological action and clinical results of Omarigliptin (MARIZEV^® tablet), a novel dipeptidyl peptidase-4 inhibitor for once-weekly treatment of Type 2 diabetes

, 2017
Yuka Ito, Masahiko Mori, Yuki Matsumoto, Taro Okamoto   +3 more
openalex   +2 more sources

Dipeptidyl Peptidase-4 Inhibitor

Journal of the American College of Cardiology, 2012
openaire   +1 more source

Case report: Epidermolysis bullosa acquisita following dipeptidyl peptidase-4 inhibitor therapy and complicated by immune thrombocytopenic purpura. [PDF]

Front Immunol
Kawamoto H, Sasaki N, Ueda Y, Ishii N, Sawada Y.   +4 more
europepmc   +1 more source

Association of dipeptidyl peptidase‐4 inhibitor initiation at glycated haemoglobin <7.5% with reduced major clinical events mediated by low glycated haemoglobin variability [PDF]

Johnny T. K. Cheung, Aimin Yang, Hongjiang Wu, Eric S. H. Lau, Juliana Nga Man Lui, Alice P.S. Kong, Ronald C.W., Andrea O. Y. Luk, Elaine Chow, Juliana C.N. Chan   +9 more
openalex   +1 more source

Acarbose With Comparable Glucose-Lowering but Superior Weight-Loss Efficacy to Dipeptidyl Peptidase-4 Inhibitors: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials

, 2020
Fang Zhang, Shishi Xu, Lizhi Tang, Xiaohui Pan, Nanwei Tong   +4 more
openalex   +1 more source

Identification of distinct epitopes in dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid. [PDF]

Sci Adv
Mai S, Mai Y, Ujiie I, Izumi K, Natsuga K, Nishie W, Ujiie H.   +6 more
europepmc   +1 more source

The influence of dipeptidyl peptidase-4 inhibitor on the progression of type B intramural hematoma. [PDF]

Front Cardiovasc Med, 2022
Chen Q, Jiang D, Shan Z.
europepmc   +1 more source